Jung-Jyh Hung MD, PhD
Personal Particulars
Employment:
2007-2010 Attending Surgeon, Division of Thoracic Surgery,Department of Surgery,
Cathay General Hospital, Taipei, Taiwan
2010-current Attending Surgeon, Division of Thoracic Surgery, Department of
Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
Academic Appointment:
Professor, School of Medicine, National Yang-Ming University
No. 155, Section 2, Li-Nong Street, Taipei 112, Taiwan
Education and Training:
1995-2002 M.D. School of Medicine, National Yang-Ming University, Taipei, Taiwan
2002-2007 Residency in Surgery. Taipei Veterans General Hospital, Taipei, Taiwan
2007-2010 Ph.D. Institute of Clinical Medicine, National Yang-Ming University, Taipei,
Taiwan
Professional Affiliation:
- Taiwan Surgical Association
- Taiwan Association of Thoracic & Cardiovascular Surgery
- Taiwan Society of Pulmonary and Critical Care Medicine
- Taiwan Lung Cancer Society
- Chinese Oncology Society
- Formosa Association of the Surgery for Trauma
- American Association for Cancer Research
- International Association for the Study of Lung Cancer
Publication:
1. Hung JJ,* Yeh YC, Jeng WJ, Chien HC, Wu YC,* Chou TY,* Hsu WH.* Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma. J Thorac Oncol 2015;10:1328-1336. (SCI, Impact factor: 5.282; Rank: 7/57, 12.3%, Respiratory system) (*Corresponding author)
2. Kuo YC, Wu HT, Hung JJ, Chou TY, Teng SC, Wu KJ. Nijmegen breakage syndrome protein 1 (NBS1) modulates hypoxia inducible factor-1α (HIF-1α) stability and promotes in vitro migration and invasion under ionizing radiation. Int J Biochem Cell Biol 2015;64:229-238. (SCI, Impact factor: 4.046; Rank: 68/184, 36.9%, Cell biology)
3. Hung JJ,* Yeh YC, Jeng WJ, Wu KJ, Huang BS, Wu YC,* Chou TY,* Hsu WH.* Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival. J Clin Oncol 2014;32:2357-2364. (SCI, Impact factor: 18.428; Rank: 6/211, 2.8%, Oncology) (*Corresponding author)
4. Chen HF, Huang CH, Liu CJ, Hung JJ, Hsu CC, Teng SC, Wu KJ. Twist1 induces endothelial differentiation of tumor cells through the Jagged1-KLF4 axis. Nat Commun 2014;5:4697. (SCI, Impact factor: 11.470; Rank: 3/56, 5.3%, Multidisciplinary Sciences)
5. Hung JJ,* Jeng WJ, Chou TY, Hsu WH, Wu KJ, Huang BS, Wu YC.* Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma. Ann Surg 2013;258:1079-86. (SCI, Impact factor: 8.327; Rank: 1/198, 0.5%, Surgery) (*Corresponding author)
6. Liu CY, Hung JJ,* Wang BY, Hsu WH, Wu YC. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer. Eur Respir J 2013;41:649-55. (SCI, Impact factor: 7.636; Rank: 4/57, 7.0%, Respiratory system) (*Co-first author)
7. Duann CW, Hung JJ, Hsu PK, Huang CS, Hsieh CC, Hsu HS, Wu YC, Hsu WH. Surgical outcomes in lung cancer presenting as ground-glass opacities of 3 cm or less: A review of 5 years' experience. J Chin Med Assoc 2013;76:693-7. (SCI, Impact factor: 0.845; Rank: 106/153, 69.2%, Medicine, general and internal)
8. Hung JJ,* Jeng WJ, Hsu WH, Chou TY, Wu YC.* Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer. Chest 2012;142:141-50. (SCI, Impact factor: 7.483; Rank: 5/57, 8.7%, Respiratory system) (*Corresponding author)
9. Hung JJ,* Jeng WJ, Hsu WH, Huang BS, Wu YC.* Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer. J Thorac Oncol 2012;7:397-405. (SCI, Impact factor: 5.282; Rank: 7/57, 12.3%, Respiratory system) (*Corresponding author)
10. Hung JJ, Jeng WJ, Hsu WH, Chou TY, Huang BS, Wu YC. Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non-Small-Cell Lung Cancer. J Thorac Oncol 2012;7:1115-23. (SCI, Impact factor: 5.282; Rank: 7/57, 12.3%, Respiratory system)
11. Wei DC, Yeh YC, Hung JJ,* Chou TY, Wu YC, Lu PJ, Cheng HC, Hsu YL, Kuo YL, Chen KY, Lai JM. Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. Cancer Sci 2012;103:731-8. (SCI, Impact factor: 3.523; Rank: 72/211, 34.1%, Oncology) (*Co-first author)
12. Wu CY, Hung JJ,* Wu KJ. Linkage between Twist1 and Bmi1: Molecular mechanism of cancer metastasis/stemness and clinical implications. Clin Exp Pharmacol Physiol 2012;39:668-73. (SCI, Impact factor: 2.372; Rank: 126/254, 49.6%, Pharmacology and pharmacy) (*Co-first author)
13. Hung JJ, Hsueh CT, Chen KH, Hsu WH, Wu YC. Clinical significance of E2F1 protein expression in non-small cell lung cancer. Exp Hematol Oncol 2012;1:18.
14. Wang BY, Wu YC, Hung JJ, Hsu PK, Hsieh CC, Huang CS, Hsu WH. Prognosis of non-small-cell lung cancer with unexpected pleural spread at thoracotomy. J Surg Res 2011;169:e1-5. (SCI, Impact factor: 1.936; Rank: 78/198, 39.3%, Surgery)
15. Hung JJ,* Jeng WJ, Hsu WH, Wu KJ, Chou TY, Hsieh CC, Huang MH, Liu JS, Wu YC.* Prognostic factors of post-recurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 2010;65:241-5. (SCI, Impact factor: 8.290; Rank: 3/57, 5.2%, Respiratory system) (*Corresponding author)
16. Hung JJ, Jeng WJ, Hsu WH, Lin SF, Hsieh CC, Huang BS, Huang MH, Liu JS, Chou TY, Wu YC. Prognostic factors in pathological stage IB non-small cell lung cancer greater than 3 cm. Eur Respir J 2010;36:1355-61. (SCI, Impact factor: 7.636; Rank: 4/57, 7.0%, Respiratory system)
17. Wang BY, Hung JJ,* Jeng WJ, Hsu WH, Hsieh CC, Huang MH, Huang BS, Liu JS, Wu YC. Surgical Outcomes in Resected Non-small Cell Lung Cancer ≤ 1 cm in Diameter. J Chin Med Assoc 2010;73:308-13. (SCI, Impact factor: 0.845; Rank: 106/153, 69.2%, Medicine, general and internal) (*Co-first author)
18. Hung JJ,* Jeng WJ, Hsu WH, Liu JS, Wu YC. EGFR mutations in non-small-cell lung cancer. Lancet Oncol 2010;11:412-3. (SCI, Impact factor: 24.690; Rank: 3/211, 1.4%, Oncology) (*Corresponding author) (Letter to the Editor)
19. Hung JJ,* Jeng WJ, Liu JS. Post-treatment Endoscopic Biopsy for Prediction of Pathologic Response in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer. Ann Surg 2010;251:990. (SCI, Impact factor: 8.327; Rank: 1/198, 0.5%, Surgery) (*Corresponding author) (Letter to the Editor)
20. Hung JJ. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer (Br J Surg 2009; 96: 1058–1065). Br J Surg 2010;97:135. (SCI, Impact factor: 5.542; Rank: 5/198, 2.5%, Surgery) (Letter to the Editor)
21. Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, Wu YC. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009;64:192-6. (SCI, Impact factor: 8.290; Rank: 3/57, 5.2%, Respiratory system) (Editor’s choice) (Recommended by Faculty of 1000 Medicine)
22. Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS, Wu KJ. Prognostic significance of hypoxia-inducible factor-1, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 2009;64:1082-9. (SCI, Impact factor: 8.290; Rank: 3/57, 5.2%, Respiratory system)
23. Hung JJ,* Jeng WJ, Liu JS. Lung-Cancer Staging with PET-CT. N Engl J Med 2009;361:1606-7. (SCI, Impact factor: 55.873; Rank: 1/153, 0.6%, Medicine, general and internal) (*Corresponding author) (Letter to the Editor)
24. Hung JJ,* Jeng WJ, Liu JS. Prediction of Perioperative Mortality after Lung Cancer Resection in the Elderly. Am J Respir Crit Care Med 2009;180:794. (SCI, Impact factor: 12.996; Rank: 1/57, 1.7%, Respiratory system) (*Corresponding author) (Letter to the Editor)
25. Hung JJ,* Jeng WJ, Liu JS, Hsu WH. Differential diagnosis and management of focal pulmonary ground-glass opacities. Eur Respir J 2009;34:1008-9. (SCI, Impact factor: 7.636; Rank: 4/57, 7.0%, Respiratory system) (*Corresponding author) (Letter to the Editor)
26. Hung JJ, Liu JS, Wu YC, Hsu WH. The Effect of Tumor Size on Non–Size-Based Descriptors in Staging of Stage I Non-small Cell Lung Cancer. Chest 2009;135:1695. (SCI, Impact factor: 7.483; Rank: 5/57, 8.7%, Respiratory system) (Letter to the Editor)
27. Hung JJ. Spontaneous rupture of the oesophagus (Br J Surg 2008; 95: 1115-1120). Br J Surg 2009;96:951. (SCI, Impact factor: 5.542; Rank: 5/198, 2.5%, Surgery) (Letter to the Editor)
28. Hung JJ, Liu JS, Hsu WH. Prognostic significance of visceral pleural invasion and tumor size in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;138:260-1. (SCI, Impact factor: 4.168; Rank: 12/198, 6.0%, Surgery) (Letter to the Editor)
29. Hung JJ, Hsieh CC, Lin SC, Wang LS. Squamous Cell Carcinoma in a Large Epiphrenic Esophageal Diverticulum. Dig Dis Sci 2009;54:1365-8. (SCI, Impact factor: 2.613; Rank: 38/76, 50.0%, Gastroenterology and Hepatology)
30. Hung JJ, Liu JS, Hsu WH. Sclerosing hemangioma with an air halo. J Thorac Cardiovasc Surg 2008;136:1365-7. (SCI, Impact factor: 4.168; Rank: 12/198, 6.0%, Surgery)
31. Hung JJ, Chou TY, Sun CH, Liu JS, Hsu WH. Primary Synovial Sarcoma of the Posterior Chest Wall. Ann Thorac Surg 2008;85:2120-2. (SCI, Impact factor: 3.849; Rank: 16/198, 8.0%, Surgery)
32. Hung JJ, Li AF, Liu JS, Lin YS, Hsu WH. Esophageal Carcinosarcoma with Basaloid Squamous Cell Carcinoma and Osteosarcoma. Ann Thorac Surg 2008;85:1102-4. (SCI, Impact factor: 3.849; Rank: 16/198, 8.0%, Surgery)
33. Hung JJ, Wang CY, Huang MH, Huang BS, Hsu WH, Wu YC. Prognostic Factors in Resected Stage I Non-small Cell Lung Cancer of Diameter 3 cm or Less: Visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg 2007;134:638-43. (SCI, Impact factor: 4.168; Rank: 12/198, 6.0%, Surgery)
34. Hung JJ, Hsu HS, Huang CS, Yang KY. Tracheo-esophageal fistula and tracheo-subclavian artery fistula after tracheostomy. Eur J Cardiothorac Surg 2007;32:676-8. (SCI, Impact factor: 3.304; Rank: 26/198, 13.1%, Surgery)
35. Hung JJ, Lin SC, Hsu WH. Pancoast Syndrome Caused by Metastasis to the Superior Mediastinum of Hepatocellular Carcinoma. Thorac Cardiovasc Surg 2007;55:463-5. (SCI, Impact factor: 0.979; Rank: 139/198, 70.2%, Surgery)
36. Hung JJ, Wu YC, Hsu HS, Wang KM, Hsu WH. Major hemorrhage and subsequent cardiac tamponade during mediastinoscopy. J Thorac Cardiovasc Surg 2007;133:269-70. (SCI, Impact factor: 4.168; Rank: 12/198, 6.0%, Surgery)
37. Hung JJ, Chow KC, Wang HW, Wang LS. Expression of Dihydrodiol Dehydrogenase and Resistance to Chemotherapy and Radiotherapy in Adenocarcinoma Cells of Lung. Anticancer Res 2006;26:2949-56. (SCI, Impact factor: 1.826; Rank: 161/211, 76.3%, Oncology)
38. Hung JJ, Hsu WH. A Huge Lipoma of the Anterior Mediastinum. Thorac Med 2007;22:351-4.
39. Hung JJ, Wu YC, Huang MH, Huang BS, Wang LS, Hsu WH. Distant Failure Pattern of Resected Stage I Non-small Cell Lung Cancer: a long-term follow-up with multivariate analysis. Formos J Surg 2006;39:227-35.
40. Hung JJ,* Yeh YC, Jeng WJ, Chien HC, Wu YC,* Chou TY,* Hsu WH.* Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma. J Thorac Oncol 2015;10:1328-1336. (SCI, Impact factor: 5.282; Rank: 7/57, 12.3%, Respiratory system) (*Corresponding author)
41. Kuo YC, Wu HT, Hung JJ, Chou TY, Teng SC, Wu KJ. Nijmegen breakage syndrome protein 1 (NBS1) modulates hypoxia inducible factor-1α (HIF-1α) stability and promotes in vitro migration and invasion under ionizing radiation. Int J Biochem Cell Biol 2015;64:229-238. (SCI, Impact factor: 4.046; Rank: 68/184, 36.9%, Cell biology)
42. Hung JJ,* Yeh YC, Jeng WJ, Wu KJ, Huang BS, Wu YC,* Chou TY,* Hsu WH.* Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival. J Clin Oncol 2014;32:2357-2364. (SCI, Impact factor: 18.428; Rank: 6/211, 2.8%, Oncology) (*Corresponding author)
43. Chen HF, Huang CH, Liu CJ, Hung JJ, Hsu CC, Teng SC, Wu KJ. Twist1 induces endothelial differentiation of tumor cells through the Jagged1-KLF4 axis. Nat Commun 2014;5:4697. (SCI, Impact factor: 11.470; Rank: 3/56, 5.3%, Multidisciplinary Sciences)
44. Hung JJ,* Jeng WJ, Chou TY, Hsu WH, Wu KJ, Huang BS, Wu YC.* Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma. Ann Surg 2013;258:1079-86. (SCI, Impact factor: 8.327; Rank: 1/198, 0.5%, Surgery) (*Corresponding author)
45. Liu CY, Hung JJ,* Wang BY, Hsu WH, Wu YC. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer. Eur Respir J 2013;41:649-55. (SCI, Impact factor: 7.636; Rank: 4/57, 7.0%, Respiratory system) (*Co-first author)
46. Duann CW, Hung JJ, Hsu PK, Huang CS, Hsieh CC, Hsu HS, Wu YC, Hsu WH. Surgical outcomes in lung cancer presenting as ground-glass opacities of 3 cm or less: A review of 5 years' experience. J Chin Med Assoc 2013;76:693-7. (SCI, Impact factor: 0.845; Rank: 106/153, 69.2%, Medicine, general and internal)
47. Hung JJ,* Jeng WJ, Hsu WH, Chou TY, Wu YC.* Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer. Chest 2012;142:141-50. (SCI, Impact factor: 7.483; Rank: 5/57, 8.7%, Respiratory system) (*Corresponding author)
48. Hung JJ,* Jeng WJ, Hsu WH, Huang BS, Wu YC.* Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer. J Thorac Oncol 2012;7:397-405. (SCI, Impact factor: 5.282; Rank: 7/57, 12.3%, Respiratory system) (*Corresponding author)
49. Hung JJ, Jeng WJ, Hsu WH, Chou TY, Huang BS, Wu YC. Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non-Small-Cell Lung Cancer. J Thorac Oncol 2012;7:1115-23. (SCI, Impact factor: 5.282; Rank: 7/57, 12.3%, Respiratory system)
50. Wei DC, Yeh YC, Hung JJ,* Chou TY, Wu YC, Lu PJ, Cheng HC, Hsu YL, Kuo YL, Chen KY, Lai JM. Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. Cancer Sci 2012;103:731-8. (SCI, Impact factor: 3.523; Rank: 72/211, 34.1%, Oncology) (*Co-first author)
51. Wu CY, Hung JJ,* Wu KJ. Linkage between Twist1 and Bmi1: Molecular mechanism of cancer metastasis/stemness and clinical implications. Clin Exp Pharmacol Physiol 2012;39:668-73. (SCI, Impact factor: 2.372; Rank: 126/254, 49.6%, Pharmacology and pharmacy) (*Co-first author)
52. Hung JJ, Hsueh CT, Chen KH, Hsu WH, Wu YC. Clinical significance of E2F1 protein expression in non-small cell lung cancer. Exp Hematol Oncol 2012;1:18.
53. Wang BY, Wu YC, Hung JJ, Hsu PK, Hsieh CC, Huang CS, Hsu WH. Prognosis of non-small-cell lung cancer with unexpected pleural spread at thoracotomy. J Surg Res 2011;169:e1-5. (SCI, Impact factor: 1.936; Rank: 78/198, 39.3%, Surgery)
54. Hung JJ,* Jeng WJ, Hsu WH, Wu KJ, Chou TY, Hsieh CC, Huang MH, Liu JS, Wu YC.* Prognostic factors of post-recurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 2010;65:241-5. (SCI, Impact factor: 8.290; Rank: 3/57, 5.2%, Respiratory system) (*Corresponding author)
55. Hung JJ, Jeng WJ, Hsu WH, Lin SF, Hsieh CC, Huang BS, Huang MH, Liu JS, Chou TY, Wu YC. Prognostic factors in pathological stage IB non-small cell lung cancer greater than 3 cm. Eur Respir J 2010;36:1355-61. (SCI, Impact factor: 7.636; Rank: 4/57, 7.0%, Respiratory system)
56. Wang BY, Hung JJ,* Jeng WJ, Hsu WH, Hsieh CC, Huang MH, Huang BS, Liu JS, Wu YC. Surgical Outcomes in Resected Non-small Cell Lung Cancer ≤ 1 cm in Diameter. J Chin Med Assoc 2010;73:308-13. (SCI, Impact factor: 0.845; Rank: 106/153, 69.2%, Medicine, general and internal) (*Co-first author)
57. Hung JJ,* Jeng WJ, Hsu WH, Liu JS, Wu YC. EGFR mutations in non-small-cell lung cancer. Lancet Oncol 2010;11:412-3. (SCI, Impact factor: 24.690; Rank: 3/211, 1.4%, Oncology) (*Corresponding author) (Letter to the Editor)
58. Hung JJ,* Jeng WJ, Liu JS. Post-treatment Endoscopic Biopsy for Prediction of Pathologic Response in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer. Ann Surg 2010;251:990. (SCI, Impact factor: 8.327; Rank: 1/198, 0.5%, Surgery) (*Corresponding author) (Letter to the Editor)
59. Hung JJ. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer (Br J Surg 2009; 96: 1058–1065). Br J Surg 2010;97:135. (SCI, Impact factor: 5.542; Rank: 5/198, 2.5%, Surgery) (Letter to the Editor)
60. Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, Wu YC. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009;64:192-6. (SCI, Impact factor: 8.290; Rank: 3/57, 5.2%, Respiratory system) (Editor’s choice) (Recommended by Faculty of 1000 Medicine)
61. Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS, Wu KJ. Prognostic significance of hypoxia-inducible factor-1, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 2009;64:1082-9. (SCI, Impact factor: 8.290; Rank: 3/57, 5.2%, Respiratory system)
62. Hung JJ,* Jeng WJ, Liu JS. Lung-Cancer Staging with PET-CT. N Engl J Med 2009;361:1606-7. (SCI, Impact factor: 55.873; Rank: 1/153, 0.6%, Medicine, general and internal) (*Corresponding author) (Letter to the Editor)
63. Hung JJ,* Jeng WJ, Liu JS. Prediction of Perioperative Mortality after Lung Cancer Resection in the Elderly. Am J Respir Crit Care Med 2009;180:794. (SCI, Impact factor: 12.996; Rank: 1/57, 1.7%, Respiratory system) (*Corresponding author) (Letter to the Editor)
64. Hung JJ,* Jeng WJ, Liu JS, Hsu WH. Differential diagnosis and management of focal pulmonary ground-glass opacities. Eur Respir J 2009;34:1008-9. (SCI, Impact factor: 7.636; Rank: 4/57, 7.0%, Respiratory system) (*Corresponding author) (Letter to the Editor)
65. Hung JJ, Liu JS, Wu YC, Hsu WH. The Effect of Tumor Size on Non–Size-Based Descriptors in Staging of Stage I Non-small Cell Lung Cancer. Chest 2009;135:1695. (SCI, Impact factor: 7.483; Rank: 5/57, 8.7%, Respiratory system) (Letter to the Editor)
66. Hung JJ. Spontaneous rupture of the oesophagus (Br J Surg 2008; 95: 1115-1120). Br J Surg 2009;96:951. (SCI, Impact factor: 5.542; Rank: 5/198, 2.5%, Surgery) (Letter to the Editor)
67. Hung JJ, Liu JS, Hsu WH. Prognostic significance of visceral pleural invasion and tumor size in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;138:260-1. (SCI, Impact factor: 4.168; Rank: 12/198, 6.0%, Surgery) (Letter to the Editor)
68. Hung JJ, Hsieh CC, Lin SC, Wang LS. Squamous Cell Carcinoma in a Large Epiphrenic Esophageal Diverticulum. Dig Dis Sci 2009;54:1365-8. (SCI, Impact factor: 2.613; Rank: 38/76, 50.0%, Gastroenterology and Hepatology)
69. Hung JJ, Liu JS, Hsu WH. Sclerosing hemangioma with an air halo. J Thorac Cardiovasc Surg 2008;136:1365-7. (SCI, Impact factor: 4.168; Rank: 12/198, 6.0%, Surgery)
70. Hung JJ, Chou TY, Sun CH, Liu JS, Hsu WH. Primary Synovial Sarcoma of the Posterior Chest Wall. Ann Thorac Surg 2008;85:2120-2. (SCI, Impact factor: 3.849; Rank: 16/198, 8.0%, Surgery)
71. Hung JJ, Li AF, Liu JS, Lin YS, Hsu WH. Esophageal Carcinosarcoma with Basaloid Squamous Cell Carcinoma and Osteosarcoma. Ann Thorac Surg 2008;85:1102-4. (SCI, Impact factor: 3.849; Rank: 16/198, 8.0%, Surgery)
72. Hung JJ, Wang CY, Huang MH, Huang BS, Hsu WH, Wu YC. Prognostic Factors in Resected Stage I Non-small Cell Lung Cancer of Diameter 3 cm or Less: Visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg 2007;134:638-43. (SCI, Impact factor: 4.168; Rank: 12/198, 6.0%, Surgery)
73. Hung JJ, Hsu HS, Huang CS, Yang KY. Tracheo-esophageal fistula and tracheo-subclavian artery fistula after tracheostomy. Eur J Cardiothorac Surg 2007;32:676-8. (SCI, Impact factor: 3.304; Rank: 26/198, 13.1%, Surgery)
74. Hung JJ, Lin SC, Hsu WH. Pancoast Syndrome Caused by Metastasis to the Superior Mediastinum of Hepatocellular Carcinoma. Thorac Cardiovasc Surg 2007;55:463-5. (SCI, Impact factor: 0.979; Rank: 139/198, 70.2%, Surgery)
75. Hung JJ, Wu YC, Hsu HS, Wang KM, Hsu WH. Major hemorrhage and subsequent cardiac tamponade during mediastinoscopy. J Thorac Cardiovasc Surg 2007;133:269-70. (SCI, Impact factor: 4.168; Rank: 12/198, 6.0%, Surgery)
76. Hung JJ, Chow KC, Wang HW, Wang LS. Expression of Dihydrodiol Dehydrogenase and Resistance to Chemotherapy and Radiotherapy in Adenocarcinoma Cells of Lung. Anticancer Res 2006;26:2949-56. (SCI, Impact factor: 1.826; Rank: 161/211, 76.3%, Oncology)
77. Hung JJ, Hsu WH. A Huge Lipoma of the Anterior Mediastinum. Thorac Med 2007;22:351-4.
78. Hung JJ, Wu YC, Huang MH, Huang BS, Wang LS, Hsu WH. Distant Failure Pattern of Resected Stage I Non-small Cell Lung Cancer: a long-term follow-up with multivariate analysis. Formos J Surg 2006;39:227-35.
最後更新: